Please login to the form below
Illumina
This page shows the latest Illumina news and features for those working in and with pharma, biotech and healthcare.
UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen
There’s no question that ONT needs to build scale quickly if it is to take on the likes of Illumina, which reported sales of $2.75bn last year compared to ... is not as accurate or high-throughput as Illumina’s, and the latter will continue to
Latest news
-
Loxo, Bayer get quick FDA review for ‘precision’ cancer drug
To try to address that issue, Loxo formed a partnership earlier this year with Illumina to develop a companion diagnostic – called TruSight Tumour 170 – that will use sequencing to identify whether
-
Daily Brief: Calls for early Brexit deal for science and innovation, Gottlieb threatens to name and shame
Genomics. Illumina buys genome data analysis firm. Genome sequencing leader Illumina has paid $100m for Edico Genome, a company which has developed software to speed-up the reading of genetic data. ... President of Product Development at Illumina.
-
Roche buys gene sequencing firm
Illumina to the altar. ... which is predicted to swell to $8.7bn by 2020 but at the moment is still dominated by Illumina with around 75% market share,.
-
AstraZeneca joins Genomics England consortium
AstraZeneca joins Genomics England consortium. Combines with other pharma firms such as Illumina to utilise genetic data to create new medicines. ... It joins another of other firms, including Biogen and Illumina, who have signed up to the project.
-
NHS set to deliver 'world-leading' genomics centres
After samples are collected, they will be sent securely to its gene sequencing partner Illumina - results will be returned to the NHS for validation and clinical action.
More from news
Approximately 7 fully matching, plus 20 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2017
IBM Watson Health/ Illumina. Partnership to integrate Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumour sequencing process to expand access to genomic data.
-
Digital: Fallacy or the Future Face of Pharma Marketing?
Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
-
Digital: Fallacy or the Future Face of Pharma Marketing?
Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
-
Pharma deals during July 2013
Roche, rumoured to be interested in Alexion, may still be smarting from the battle to try and take over Illumina last year.
-
What can pharma learn from Olympic sports coverage?
So where could Roche go next? With its unsuccessful takeover bid for Illumina, it could be a move into genetic sequencing to augment their oncology capability and more besides.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Illumina expands board of directors
Illumina expands board of directors. John Thompson brings experience from IBM and Microsoft. ... San Diego, US-based Illumina has appointed John Thompson to its board of directors.
-
GlobalData makes Americas appointment
He has spent 18 years in varous positions in the life sciences consulting industry, including roles at, Bionest Partners, IMS Management Consulting, and Illumina Inc.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Key Factors Contributing Towards Growth of the LIMS Market During 2016-2026
Abbott Park, U.S.A), Genologics (Illumina, Inc.), Promium LLc. LabLynx Inc., Autoscribe Informatics, Novatek International, Core Informatics etc.
-
Why is the UK lagging behind the rest of Europe in cancer survival?
To bring home the importance of this diagnostic technology, the CEO of Illumina (a top DNA sequencing firm) believes this technology will become the “ stethoscope for the next 200 years.” A
-
Dan Coffin joins London Headquarters as Director
Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm.
-
Dan Coffin joins London Headquarters as Director
Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm.
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior Account Manager
-
Negotiable
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director
-
£48, 000 - £60, 000
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Associate Medical Director
-
Highly Competitive
-
Associate Director
-
£75, 000-90, 000
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
Senior Medical Writer
-
Great salary and benefits
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
Subscribe to our email news alerts
- Stem Cell Therapies Market Volume Forecast and Value Chain Analysis 2015 - 2025
- Small Animal Imaging (In Vivo) Market to Witness Robust Expansion throughout the Forecast 2016- 2026
- Advance Renal Cell Carcinoma Therapeutics Market Prophesied to Grow at a Faster Pace by 2026
- Nasal Implant Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026
- Equine Veterinary Therapeutics Market Growth, Trends, Absolute Opportunity and Value Chain 2016-2026
- Limb Salvage Systems Market Value Share, Supply Demand, share and Value Chain 2016-2026
PMHub
Just::Health Communications
Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
